Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study. [electronic resource]
Producer: 19920521Description: 1129-35 p. digitalISSN:- 0735-1097
- Adrenergic beta-Antagonists -- administration & dosage
- Cause of Death
- Chi-Square Distribution
- Drug Evaluation
- Humans
- Infusions, Intravenous
- Myocardial Infarction -- drug therapy
- Prognosis
- Recombinant Proteins -- administration & dosage
- Survival Rate
- Thrombolytic Therapy
- Time Factors
- Tissue Plasminogen Activator -- administration & dosage
- United States
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.